media

Markets

Market Nav

INCOME STATEMENT

You can view the income statement for the last 5 years.
Marksans Pharma Ltd.
( in Crs.)

ParticularsMar 23Mar 22Mar 21Mar 20Mar 19
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue1.001.001.001.001.00
      
      
INCOME     
Revenue From Operations [Net]1849.621480.121368.371129.33987.33
Other Operating Revenues2.5210.727.814.8712.74
Total Operating Revenues1852.141490.841376.181134.211000.07
      
Other Income59.3141.856.690.334.62
Total Revenue1911.451532.691382.881134.541004.69
      
EXPENSES     
Cost Of Materials Consumed612.97540.67419.76371.33412.06
Purchase Of Stock-In Trade314.78163.25311.57120.60105.85
Changes In Inventories Of FG,WIP And Stock-In Trade-6.3912.90-136.2852.95-19.90
Employee Benefit Expenses239.37220.30197.32168.42159.07
Finance Costs9.138.457.998.759.66
Depreciation And Amortisation Expenses51.8544.7836.1526.6622.80
Other Expenses352.09294.84244.20228.66210.85
Total Expenses1573.801285.181080.71977.36900.38
      
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax337.65247.51302.16157.17104.31
      
Profit/Loss Before Tax337.65247.51302.16157.17104.31
      
Tax Expenses-Continued Operations     
Current Tax71.5757.1066.6932.4123.59
Deferred Tax1.103.59-3.074.471.00
Tax For Earlier Years-0.330.010.00-0.45-0.72
Total Tax Expenses72.3360.7063.6336.4223.87
Profit/Loss After Tax And Before ExtraOrdinary Items265.32186.81238.54120.7580.44
      
Profit/Loss From Continuing Operations265.32186.81238.54120.7580.44
      
Profit/Loss For The Period265.32186.81238.54120.7580.44
      
Minority Interest0.990.000.000.000.00
Consolidated Profit/Loss After MI And Associates266.31186.81238.54120.7580.44
      
OTHER INFORMATION     
      
EARNINGS PER SHARE     
Basic EPS (Rs.)6.414.515.762.861.87
Diluted EPS (Rs.)6.414.515.762.861.87
      
DIVIDEND AND DIVIDEND PERCENTAGE     
Equity Share Dividend10.1710.234.0929.504.44
Preference Share Dividend0.000.000.005.000.00
ParticularsMar 23
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue1.00
  
INCOME 
Revenue From Operations [Net]1849.62
Other Operating Revenues2.52
Total Operating Revenues1852.14
Other Income59.31
Total Revenue1911.45
EXPENSES 
Cost Of Materials Consumed612.97
Purchase Of Stock-In Trade314.78
Changes In Inventories Of FG,WIP And Stock-In Trade-6.39
Employee Benefit Expenses239.37
Finance Costs9.13
Depreciation And Amortisation Expenses51.85
Other Expenses352.09
Total Expenses1573.80
Profit/Loss Before Exceptional, ExtraOrdinary Items And Tax337.65
Profit/Loss Before Tax337.65
Tax Expenses-Continued Operations 
Current Tax71.57
Deferred Tax1.10
Tax For Earlier Years-0.33
Total Tax Expenses72.33
Profit/Loss After Tax And Before ExtraOrdinary Items265.32
Profit/Loss From Continuing Operations265.32
Profit/Loss For The Period265.32
Minority Interest0.99
Consolidated Profit/Loss After MI And Associates266.31
OTHER INFORMATION 
EARNINGS PER SHARE 
Basic EPS (Rs.)6.41
Diluted EPS (Rs.)6.41
DIVIDEND AND DIVIDEND PERCENTAGE 
Equity Share Dividend10.17
Preference Share Dividend0.00